Search

Your search keyword '"Malucchi, Simona"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Malucchi, Simona" Remove constraint Author: "Malucchi, Simona"
233 results on '"Malucchi, Simona"'

Search Results

2. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

5. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

7. Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study

9. Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

10. Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study

11. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

12. COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients.

14. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study

15. “Better explanations” in multiple sclerosis diagnostic workup: A 3-year longitudinal study

18. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

22. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

26. Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

27. Italian multicenter observational study on real-life experience with alemtuzumab in naïve patients with aggressive multiple sclerosis

28. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

30. A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

31. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

36. Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)

39. MSJ872889_supplemental_table – Supplemental material for Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience

41. Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

42. Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience

44. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.

45. Neutralizing antibodies against IFN‐β in multiple sclerosis: antagonization of IFN‐β mediated suppression of MMPs

48. The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial

Catalog

Books, media, physical & digital resources